Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DTIL 1.82 my favorite stock I do not own, after got suckered by Goldman Sacks reduced price target from 7 to 2.
RCMT 13.01 LOD, many insiders sold recently above $22 and no insider buys since 2018.
NCPL 3.21 knew I wanted to start lower.
AEY 2.20 them 1.88, likes to play with the momo crowd.
AGRX .57 start, want lower as good trader.
DTIL 1.79.
AEY: ok alarm clock set for early predawn rise on next early rocket and "rest"
play!.
AEY 1.95 missed the earlier fun, out unless 1.60's.
RCMT now 13.58 low. deafing response pre-market, hoping to see fickle on the fence sellers remorseful for what they did. See I just "bought" a new job.
Ok convinced determined sellers, need to see them calm down and end their selling spree over maybe days?
AEY 1.74 now got my attention.
AEY added 1.78 as many times short drop before the bell?
AEY was 2.20 last night.
AEY 1.82 stuck my thumb.
MCVT:In Naz now.
Wonder what average cost is, as price will be major obstacle, for those in house personally customized treatments?
AEY 2.20 (up .79)saw too late.
TGL was a jumper early!
ATMFF me too add buy ,this and similar:
08/11/2022 14:53:39 Bought 10000 ATMFF @ 0.0182
-182.00 0.00 0.00
Thanks your comments removed the must follow at all "costs".
NUVG .12 up .04.
RCMT 5 million below estimate, hit it to $15?
RCMT 15.50 stuck thumb as all I could afford.
7 cents above whisper number of .50?
ATMFF caught the mist yesterday.
FAMI 1.21.
Re: NSRCF: Is this stock too risky (cash burn before extraction feat)?
Compelling teases.
As the power revolution prepares to move into a new phase and people realize the role graphite plays as a key raw material, a company such as NextSource Materials is likely to gain more and more attention in the coming months as it becomes the only graphite company outside of China to enter production in 2022."
https://themarketherald.ca/one-of-the-few-able-to-fill-the-ev-markets-graphite-supply-void-2022-07-27/?fbclid=IwAR0Nq143qwIeBSCOkspOHu-wAV87lqIYZ222Yy5mXEB37Yb8aOz2ZCD50N4
FAMI 1.16 sticking its head out a little?
Again 400K spent on his home base stock (NILE) despite history of porous dilutions?
CYCC maybe a pre bell buy if profit taking on this low float?
I always assume that an inventive drug Co put together from perhaps buying the majority interest in the patents of a promising
drug platform ( from a university or other drug Co.) is only focused on financing and managing the drug trials, and will usually outsource the difficult phase of the manufacturing process.
But you of course know the whole routine. Am I wrong in thinking Sloan Kettering can act like a usual drug manufacturing entity?
FAMI 1.16 running a little.
PSHG .68 after hours , sold too soon.
MSKCC did billions in buildouts, figured they would do the whole package themselves, with their research labs fluently oiling patient match-ups.........all magnified and heralded in their higher elite rated loop to attract worldwide patient population , who are eager and able to demand and willing to pay for top experimental cancer remedies.
And by the way, I am not using the word "astounding" gratuitously
to describe the obvious but not yet widely reported buildout on steroids of new unconnected in physical space, hospital affiliated wings in almost every available space (in NYC). I do not know how they find enough doctors to man those locations as well as the hundreds of new store front clinics attended to by very competent doctors.
Spoke with my "poor" doctor who is unaffiliated and only gets 1/3 of the billing the same procedure produces for the hospitals.
Also something about "non-profitable" hospitals ( extracting perhaps some mysterious benefits), also adventure capital making new inroads (like encouraging elderly who can't find their keys to call an ambulance) finding legal billing loopholes. Private sector vanity donors does fuel some stuff, but hard to explain the museum like new lobbies of some of the newer hospital expansion buildings. This is only sector in entire country , i can say I have real evidence that this is a wealthy nation.
RE; Advanced colorectal cancer.
T.V. news featuring this as a miraculous discovery, wonder if a specific neoadjuvant drug Co. co- sponsor?
https://www.mskcc.org/news-releases/asco-2022-100-complete-response-rate-mmrd-locally-advanced-rectal-cancer-seen-pivotal-immunoablative-neoadjuvant-immunotherapy-clinical-trial
NVTA, high growth ,high cash burn, high dilution , was a vise of trembling waits.
ARTW first step 2.15 bell close buy.
ATMFF if just $4 before 2023 ya get never to pay for this site again!
ATMFF if just $4 ya get never to pay for this site again!
RSLS .50 late to their own wedding at .80 today.
BDRL liked at todays lows (.12) not todays highs (.17).
ARTW yes, only one on as of this sec, my happy to buy list.